The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.
The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.
复制标题
DOI:
10.1093/cid/ciab079
复制
发表时间:
2021-12-16
期刊:
影响因子:
--
通讯作者:
Galvani AP
中科院分区:
文献类型:
--
作者:
Moghadas SM;Vilches TN;Zhang K;Wells CR;Shoukat A;Singer BH;Meyers LA;Neuzil KM;Langley JM;Fitzpatrick MC;Galvani AP
Global vaccine development efforts have been accelerated in response to the devastating coronavirus disease 2019 (COVID-19) pandemic. We evaluated the impact of a 2-dose COVID-19 vaccination campaign on reducing incidence, hospitalizations, and deaths in the United States. We developed an agent-based model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and parameterized it with US demographics and age-specific COVID-19 outcomes. Healthcare workers and high-risk individuals were prioritized for vaccination, whereas children under 18 years of age were not vaccinated. We considered a vaccine efficacy of 95% against disease following 2 doses administered 21 days apart achieving 40% vaccine coverage of the overall population within 284 days. We varied vaccine efficacy against infection and specified 10% preexisting population immunity for the base-case scenario. The model was calibrated to an effective reproduction number of 1.2, accounting for current nonpharmaceutical interventions in the United States. Vaccination reduced the overall attack rate to 4.6% (95% credible interval [CrI]: 4.3%–5.0%) from 9.0% (95% CrI: 8.4%–9.4%) without vaccination, over 300 days. The highest relative reduction (54%–62%) was observed among individuals aged 65 and older. Vaccination markedly reduced adverse outcomes, with non-intensive care unit (ICU) hospitalizations, ICU hospitalizations, and deaths decreasing by 63.5% (95% CrI: 60.3%–66.7%), 65.6% (95% CrI: 62.2%–68.6%), and 69.3% (95% CrI: 65.5%–73.1%), respectively, across the same period. Our results indicate that vaccination can have a substantial impact on mitigating COVID-19 outbreaks, even with limited protection against infection. However, continued compliance with nonpharmaceutical interventions is essential to achieve this impact. Vaccination with a 95% efficacy against disease could substantially mitigate future attack rates, hospitalizations, and deaths, even if only adults are vaccinated. Nonpharmaceutical interventions remain an important part of outbreak response as vaccines are distributed over time.
登录
查看更多内容
DOI:
10.15585/mmwr.mm6915e3
发表时间:
2020-04-17
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Garg S;Kim L;Whitaker M;O'Halloran A;Cummings C;Holstein R;Prill M;Chai SJ;Kirley PD;Alden NB;Kawasaki B;Yousey-Hindes K;Niccolai L;Anderson EJ;Openo KP;Weigel A;Monroe ML;Ryan P;Henderson J;Kim S;Como-Sabetti K;Lynfield R;Sosin D;Torres S;Muse A;Bennett NM;Billing L;Sutton M;West N;Schaffner W;Talbot HK;Aquino C;George A;Budd A;Brammer L;Langley G;Hall AJ;Fry A
通讯作者:
Fry A
DOI:
10.1016/s0140-6736(20)32009-2
发表时间:
2020-10-24
期刊:
Lancet (London, England)
影响因子:
--
作者:
Anand S;Montez-Rath M;Han J;Bozeman J;Kerschmann R;Beyer P;Parsonnet J;Chertow GM
通讯作者:
Chertow GM
影响因子:
82.9
作者:
He, Xi;Lau, Eric H. Y.;Leung, Gabriel M.
通讯作者:
Leung, Gabriel M.
影响因子:
33.9
作者:
Kimball, Anne;Hatfield, Kelly M.;Jernigan, John A.
通讯作者:
Jernigan, John A.
影响因子:
9.3
作者:
Jarvis, Christopher I.;Van Zandvoort, Kevin;Edmunds, W. John
通讯作者:
Edmunds, W. John